Northwestern Medicine scientists have uncovered an unexpected role for a well-known cancer-related protein, revealing a new ...
Prostate cancer is one of the most prevalent malignancies in men and remains a leading cause of cancer-related morbidity and mortality worldwide. For many, prostate cancer follows an indolent course, ...
Pfizer is eyeing an earlier use of its PARP inhibitor Talzenna after a positive phase 3 trial in metastatic hormone-sensitive prostate cancer (mHSPC). The phase 3 Talapro-3 trial met its primary ...
Abstract: Radiomics, the extraction of features from radiographic images using data-characterization algorithms, has gained considerable attention in prostate cancer research. Traditionally, manual ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results